Historical Context: Glutathione and the Discovery of Alternative Low-Molecular-Weight Thiols {#s001}
============================================================================================

L[ow-molecular-weight]{.smallcaps} (LMW) thiols serve a critical protective role in cells by helping maintain cytosolic proteins in their reduced state and as protection against reactive oxygen species (ROS) and reactive electrophilic species, antibiotics, as well as heavy metals. Glutathione (GSH), a tripeptide with composition γ-L-glutamyl-L-cysteinylglycine ([Fig. 1](#f1){ref-type="fig"}), is, by far, the best studied member from this class of compounds.

![**Structures of major LMW thiols in bacteria.** Glutathione is utilized as the major LMW thiol in eukaryotes and Gram-negative bacteria, mycothiol in Actinomycetes, and BSH in *Firmicutes*. Coenzyme A (CoASH) also serves as an LMW thiol in *Staphylococcus aureus* and *Bacillus anthracis*. BSH, bacillithiol; LMW, low molecular weight.](fig-1){#f1}

Although thiols were detected in tissues in the late 19th century, the discovery of GSH is appropriately attributed to the celebrated biochemist Sir Fredrick Hopkins in 1921, co-winner (with Christiaan Eijkman) of the 1929 Nobel Prize in Physiology or Medicine for his discovery of vitamins. In his seminal paper on GSH ([@B53]), Hopkins begins by giving credit to the studies of Joseph de Rey-Pailhade ([@B20]), several decades prior (1888), that led to the description of "philothion" as a cellular reductant. Despite uncertainty regarding the precise chemical composition, Hopkins proposed the name glutathione for what he surmised was a dipeptide containing Glu and Cys:

> Provisionally, for easy reference, the name Glutathione will perhaps be admissible. It leaves a link with the historic Philothion, has the same termination as Peptone, which has long served as a name for the simpler peptides, and is a sufficient reminder that the dipeptide contains glutamic acid linked to a sulphur compound ([@B53]).

Doubts about the proposed chemical composition soon emerged. Hopkins acknowledged this, and in 1929 published evidence of the general tripeptide composition of GSH as well as methods for its large-scale purification ([@B54]). These studies revealed that GSH does not contain a thione (C = S) moiety, but instead has a thiol (C-SH) ([Fig. 1](#f1){ref-type="fig"}), but the name glutathione has since been retained.

By the 1950s, the chemistry of thiols had been thoroughly investigated, and Barron ([@B6]) could conclude that GSH, as the major LMW thiol in cells, "\...protects essential -SH groups from oxidation, and it protects the tissues from the toxic effects of heavy metals." By this time, the impression had emerged that GSH was a universal constituent of cells ([@B6]). Despite the proclaimed ubiquity of GSH, by the mid-1970s, Robert Fahey\'s group had developed evidence pointing to the absence of GSH in several species of bacteria ([@B28]).

Following up on this insight, the alternative thiol designated mycothiol (MSH) was purified and structurally characterized from *Streptomyces* sp. AJ 9463 in the disulfide form ([@B119]), from *Mycobacterium bovis* ([@B125]) and from *Streptomyces clavuligerus* ([@B94]), and shown to be the major LMW thiol in most actinomycetes ([Fig. 1](#f1){ref-type="fig"}) ([@B92]). As discussed later, the biosynthetic pathways leading to MSH and to bacillithiol (BSH) are closely related. The discovery and properties of MSH have been recently reviewed ([@B27], [@B59]).

In addition to MSH, some mycobacteria also produce another LMW thiol, ergothioneine (EGT; 2-mercaptohistidine trimethylbetaine), originally discovered in the ergot fungus as reviewed in ([@B26]). Chemically, EGT is distinct from other LMW thiols in that a major fraction exists as the thione tautomer. In addition to MSH, other alternative thiols have also become appreciated for their roles as alternative LMW thiols. One of the first to be described, trypanothione \[T(SH)2; Bis-glutathionylspermidine\], is found in trypanosomatid parasites and consists of two GSH molecules linked by spermidine ([@B29]). Trypanosomes also contain ovothiol A (*N1*-methyl-4-mercaptohistidine).

Bacillithiol: Discovery, Structure Determination, and Biosynthetic Pathway {#s002}
==========================================================================

Although the absence of GSH in many bacteria was appreciated by 1978 ([@B28]), nearly 20 years would elapse before bacillithiol (BSH) would be identified as the major LMW thiol in many *Firmicutes* (low GC, Gram-positive bacteria). This phylum is represented by the model organism *Bacillus subtilis* and includes several important human pathogens. BSH has, to date, been documented in *Bacillus* and *Staphylococcus* spp., *Streptococcus agalactiae*, and *Deinococcus radiodurans* ([@B97]). In the interim, it was speculated that the function of GSH in these organisms might have been subsumed by Cys ([@B10]) or coenzyme A (CoASH) ([@B21]). The presence of a specific CoA-disulfide reductase in *Staphylococcus aureus* and *Bacillus anthracis* supports the notion that CoASH is reversibly oxidized *in vivo* and may serve as an LMW thiol ([@B21]).

BSH was initially detected by HPLC analysis, together with CoASH, as an abundant 398 Da LMW thiol during studies of thiol-dependent enzymes in *B. anthracis* ([@B99]). Independently, a thiol of this same mass was detected by mass spectrometry as the major adduct for *in vivo* oxidized OhrR protein in *B. subtilis* ([@B64]). OhrR is a DNA-binding protein with a single redox-active Cys residue in each monomer and responds to thiol oxidants by formation of mixed disulfides, including, as a dominant product, the *S*-bacillithiolated protein.

Following up on this initial discovery, rapid progress was made in a coordinated multi-laboratory effort that led to the determination of the chemical structure for BSH, and insights into its distribution ([@B97]) and biosynthetic pathway ([@B40]). The identification of the biosynthetic pathway enabled the generation of mutant strains lacking BSH, and initial insights into its physiological role. Working on the general assumption that BSH has likely supplanted GSH as an enzyme cofactor in these organisms, it was also possible to predict the presence of various different types of BSH-dependent enzymes (*e.g*., bacillithiol-*S*-transferases \[BST\], analogous to glutathionyl-*S*-transferases) and redox partners (*e.g*., bacilliredoxins \[Brx\], analogous to glutaredoxins). Even at this early stage (only two prior research papers on BSH had appeared), this enabled the presentation of an early preview of how the BSH field might evolve, and readers are referred to this prior review for a more detailed discussion of these early steps, which provides a context for the present review ([@B50]).

The structure of BSH was determined, after purification of the *S*-bimane derivative from *D. radiodurans*, to be the α-anomeric glycoside of L-cysteinyl-D-glucosamine with L-malic acid ([@B97]). Based on the chemical similarities between MSH and BSH, it was possible to identify candidate genes for the first two steps in BSH biosynthesis by homology ([@B40]). This led to the identification of a cluster of co-transcribed genes in *B. subtilis* that includes *bshA* (encoding a L-malic acid glycosyltransferase) and *bshB1* (one of two partially redundant deacetylases for conversion of GlcNAc-Mal to GlcN-Mal). This same operon also includes *mgsA* (a methylglyoxal synthase), which is of interest since (as discussed below) BSH plays a major role in methylglyoxal (MG) detoxification ([@B11]). This gene cluster is immediately upstream of and co-directional with the *panBCD* operon encoding enzymes in the CoASH biosynthetic pathway.

The *bshC* gene could not be identified by homology-based searches, but was revealed by phylogenomic comparisons (using the EMBL STRINGS web-based tool) as a gene with a high co-occurrence (and occasional co-localization) with *bshA* in bacterial genomes ([@B40]). The *bshC* gene is transcribed both from its own promoter and also as part of a two-gene operon with another predicted pantothenate biosynthesis gene, *panE* (*ylbQ*) ([@B37]).

The significance of this gene clustering and possible coordinate regulation is not yet understood, but an obvious suggestion is that the synthesis of CoASH and BSH may be positively correlated ([@B50]). Indeed, in *B. subtilis*, all of the genes required for BSH synthesis are upregulated in response to disulfide stress (*e.g*., diamide) through the action of the Spx transcription factor ([@B37]). A similar induction has also been documented in *S. aureus* ([@B111]). More broadly, genes for both BSH synthesis and BSH-dependent detoxification reactions are upregulated by several reactive oxidants and reactive electrophiles, as noted in several studies in *B. subtilis*, *B. anthracis*, and *S. aureus* \[reviewed in Perera et al. ([@B107])\].

In addition to providing a candidate gene for the last and missing step in BSH biosynthesis (*bshC*), phylogenomic profiling also provided an intriguing list of genes encoding proteins that are likely to function in core BSH metabolism. These included several genes of previously unassigned function (so-called y-genes). The *ypdA* gene encodes a putative thioredoxin reductase (TrxR) homolog and is postulated to function as a bacillithiol disulfide (BSSB) reductase, although experimental evidence is still lacking. Two others (*yqiW* and *yphP*) encode proteins with DUF1094 domains (domain of unknown function containing a conserved Cys-x-Cys motif), and YphP was shown to be active as a disulfide isomerase ([@B22]). This led to the prediction that these proteins might function as Brx for the reduction of *S*-bacillithiolated proteins, as described later. Finally, *ytxJ* was found to encode another putative redox-active protein related to Trx that also presumably functions in BSH metabolism.

Identification of the biosynthetic genes for BSH enabled the generation of mutants lacking this thiol, confirming that BSH is non-essential. Mutants lacking the ability to synthesize BSH are sensitive to a variety of oxidative and electrophilic stress conditions in *B. subtilis* and *S. aureus* ([@B14], [@B15], [@B40], [@B111], [@B114]). Moreover, it quickly became apparent that a previous suggestion that the *B. subtilis* FosB fosfomycin resistance protein might utilize Cys as a cofactor ([@B10]) was incorrect. FosB (as described in more detail later) is a BSH-dependent enzyme, and cells lacking either *fosB* or BSH biosynthesis are equally sensitive to fosfomycin in *B. subtilis* and *S. aureus* ([@B40], [@B111]). In practice, this provides a very convenient (although indirect) assay for BSH levels in *B. subtilis* ([@B40]).

Chemical Properties of BSH {#s003}
==========================

A key challenge for the further investigation of BSH was the need to obtain quantities that are sufficient for chemical and biochemical characterization. The development of methods for the chemical synthesis of BSH ultimately met this need. Chris Hamilton reported both a complete chemical synthesis and a hybrid chemoenzymatic route taking advantage of the ability of purified BshA to provide the D-GlcNAc-L-Mal precursor ([@B121]). These approaches provided access to not only BSH but also BSSB and to the biosynthetic intermediates GlcNAc-Mal and GlcN-Mal ([Fig. 2](#f2){ref-type="fig"}). A complete chemical synthesis was also reported by Richard Armstrong\'s laboratory in which BSH could be obtained in 8--9% yield after 11 chemical steps ([@B62]). Purified BSH has facilitated the development of a detailed understanding of the redox chemistry and ionization behavior of BSH ([@B120]), the generation of specific BSH antibodies (an important tool for the study of *S*-bacillithiolation) ([@B15]), and provides a necessary cofactor for the study of BSH-dependent enzymes.

![**Biosynthesis pathway of BSH and BSH-dependent detoxification.** In the BSH synthesis pathway of *Bacillus subtilis*, the glycosyltransferase BshA first adds GlcNAc to malate-producing GlcNAc-Mal. Then, the paralog *N*-deacetylases BshB1 and BshB2 catalyze deacetylation of GlcNAc-Mal, and BshC adds cysteine (presumably in an unidentified activated form) to GlcN-Mal, producing BSH. Detoxification of toxins, xenobiotics, or electrophiles involves their conjugation with BSH by the BSH-*S*-transferase BstA, generating BS-conjugates that are cleaved by the deacetylase BshB2 (Bca) to CysS-conjugates and GlcN-Mal used for BSH recycling. The CysS-conjugates are exported from the cells as mercapturic acid derivatives. In *S. aureus*, only one BshB-like enzyme is present that functions both as deacetylase and amidase and is essential for BSH biosynthesis.](fig-2){#f2}

A detailed chemical study of BSH redox and ionization properties indicates that the BSH thiol is more acidic than Cys or GSH, with a higher fraction in the reactive thiolate state at physiological pH ([@B120]). For example, at pH 7.7, an estimated 22% of BSH is in the bacillithiolate (BS^−^) form compared with 14.5% for Cys. The standard thiol redox potential for the BSH, BSSB couple (−221 mV) is much closer to that of free Cys (−223 mV) compared with GSH (−240 mV). Considering the relative abundance of Cys, CoASH, and BSH in the cell, it was concluded that BSH (which is present at levels near 1 m*M* during growth in *B. subtilis* and *S. aureus*) is the dominant LMW thiol, with levels of the BSH thiolate exceeding those of CoASH and Cys thiolates by ∼10--100-fold ([@B111], [@B120]).

The chemistry of LMW thiol redox buffers is dominated by the interconversion of the reduced (thiol) and oxidized (disulfide) forms, and this chemistry accounts for their role in maintaining proteins in their reduced states in the cytosol. However, the thiolate anion can also serve as a nucleophile in conjugate addition reactions as commonly employed in detoxification pathways. For BSH, these reactions are mediated by BST enzymes, analogous to the well-characterized GST enzymes ([Fig. 3A, B](#f3){ref-type="fig"}). The best characterized representative for this type of enzyme to date is FosB, as noted earlier.

![**The functions of BSH-dependent detoxification enzymes in** ***B.*** ***subtilis*** **and** ***S. aureus.*** BSH functions in detoxification of reactive oxygen and electrophilic species, HOCl, and antibiotics, such as fosfomycin in *B. subtilis* and *S. aureus*. **(A)** BSH is a cofactor for the thiol *S*-transferase FosB that adds BSH to fosfomycin for its detoxification. **(B)** Electrophiles, xenobiotics, and toxins (RX) are conjugated to BSH by the BSH *S*-transferase BstA to form BS-conjugates (BSR), which are cleaved by the BSH *S*-conjugate amidase BshB2 (Bca) to CysSR and a mercapturic acid (AcCySR) that is exported from the cell. **(C)** BSH functions in methylglyoxal detoxification as a cofactor for the glyoxalases I/II (GlxA/B) in *B. subtilis.* GlxA converts BS-hemithioacetal to *S*-lactoyl-BSH that is hydrolyzed by GlxB to D-lactate. **(D)** AdhA is a thiol-dependent formaldehyde dehydrogenase that is induced under FA stress ([@B98]), likely converting *S*-hydroxymethyl-BSH to *S*-formyl-BSH. In the final step, BSH and formate are released by an unidentified S-formyl-BSH hydrolase. **(E)** Unknown thiol-dependent peroxidases or peroxiredoxins (Bpx) might function in peroxide detoxification. *Question marks* indicate uncharacterized reactions.](fig-3){#f3}

Oxidized disulfides can also react with hydrogen sulfide (H~2~S), a metabolite produced by sulfate-reducing bacteria and also serving as a secondary messenger in mammalian systems ([@B7]). H~2~S exists predominantly as the hydrosulfide anion (HS^−^), which reacts with BSSB to generate BSH and BSSH (bacillithiol persulfide). *S. aureus* was recently shown to contain an inducible system that functions to detoxify reactive persulfides. The CstB protein, a persulfide dioxygenase sulfurtransferase, oxidizes BSSH (as well as other LMW thiol persulfides) in the presence of sulfite to generate reduced thiols (BSH) and thiosulfate ([@B122]). These authors also suggest that previously noted enzymes with a homology to CoASH disulfide reductases (CoA disulfide reductase-rhodanese homology domain protein; CoADR-RHD) may actually function as reductases for the CoASSH persulfide. The general prevalence of persulfides in bacterial physiology, and the various means for their detoxification, is not yet fully understood.

Biochemical Mechanism of BSH Biosynthesis {#s004}
=========================================

Since BSH plays a critical role in antibiotic detoxification and oxidative stress responses, the enzymes involved in BSH biosynthesis are attractive targets for novel antibiotic development. In fact, *S. aureus* strains unable to produce BSH are compromised for survival in the presence of macrophages and neutrophils ([@B111]). BshA, BshB, and BshC catalyze the enzymatic synthesis of BSH ([Fig. 2](#f2){ref-type="fig"}). BshA is homologous to *M*ycobacterium *tuberculosis* MshA and is a GT-4 class glycosyltransferase that is required for the first committed step in BSH biosynthesis. BshA catalyzes the addition of UDP-N-acetylglucosamine (UDP-GlcNAc) to L-malate through a metal-independent SN1-like mechanism, forming N-acetylglucosaminyl-malate (GlcNAc-Mal) and free UDP ([@B130], [@B133]). Structural and functional studies suggest that the release of the UDP-leaving group and nucleophilic attack by L-malate occur on the same face of the hexose sugar and are asynchronous, resulting in the formation of a short-lived oxocarbenium intermediate ([@B133]).

The second step of BSH biosynthesis is catalyzed by BshB, an N-acetylhydrolase, that generates glucosamine malate (GlcN-Mal) from GlcNAc-Mal. Genetic studies indicate the presence of one or more functionally redundant proteins in *B. subtilis*, *B. anthracis*, and *B. cereus* ([@B31], [@B40]). In *B. subtilis*, strains lacking BshB1 still produced detectible levels of BSH ([@B40]). However, BSH is completely absent on inactivation of both BshB1 and a second deacetylase BshB2, encoded by *bshB2* ([@B40]). The same overlapping roles in BSH synthesis were observed for the two BshB-paralogs BA1557 and BA3888 in *B. anthracis* as well as for BC1534 and BC3461 in *B. cereus* ([@B31]). Biochemical evidence was provided that both BshB-paralogs (BA1557 and BA3888) and the orthologs in *B. cereus* have BshB activity and catalyze the N-deacetylation of GlcNAc-Mal ([@B31]). In contrast, *S. aureus* only encodes a single BshB-like protein that is essential for BSH synthesis and has a dual function as BSH conjugate amidase (Bca) ([@B114]).

Redundancy has been observed also for MSH biosynthesis, where the deacetylation can be carried out by either the BshB-like enzyme MshB or the "moonlighting" enzyme Mca (mycothiol-S-conjugate amidase). The primary role of Mca is in detoxification of xenobiotic compounds through the cleavage of MSH conjugates, resulting in GlcN-myo-inositol and the Cys-*S*-conjugate (mercapturic acid) that is exported from the cell ([@B93]).

Biochemical studies of the BshB-paralogs of *B. anthracis* and *B. cereus* identified only BA3888 as a bacillithiol-*S*-conjugate amidase (Bca) able to hydrolyze the amide linkage of bacillithiol-*S*-bimane (BSmB) to liberate GlcNAc-Mal ([@B31]). The reaction proceeds *via* a Zn^2+^ dependent acid-base catalysis. The active site is highly conserved, the Zn^2+^ is coordinated by two histidine residues and one aspartate (His12, His113, and Asp15), and the residues involved in catalysis await identification. Bca activity is highly specific to the methyl aglycone, as suggested by its low enzymatic activity when tested with BSH analogs where the methyl aglycone was replaced with an uncharged methyl or benzyl group. The *in vivo* contribution of Bca to BSH biosynthesis and the physiological substrates of Bca remain to be identified.

The addition of Cys to GlcN-Mal, the final step in BSH biosynthesis, is catalyzed by the putative cysteine ligase, BshC. BshC was identified by a phylogenomic analysis for genes whose presence was correlated with the presence of BshA and BshB utilizing the STRING protein interaction network tool ([@B40]). Strains lacking BshC are unable to produce BSH and accumulate elevated levels of the BSH precursor GlcN-Mal ([@B40]). Interestingly, the reaction catalyzed by BshC is unknown and has yet to be reconstituted *in vitro*, possibly due to the absence of a required cofactor, substrate, or protein. Structural and functional studies suggest that BshC forms a dimer in solution through interactions between an extended coiled-coil domain from each subunit and that the BshC active sites are solvent exposed, which may allow for access by an additional protein involved in catalysis ([@B132]).

BSH and Detoxification {#s005}
======================

Fosfomycin and other antibiotics {#s006}
--------------------------------

LMW thiols play an important role in the detoxification of xenobiotic compounds and antibiotics. The most well understood LMW-based detoxification mechanism involves thiol-*S*-transferases, which catalyse the reaction of LMW thiols to a variety of substrates. The first characterized BST was FosB, involved in the detoxification of fosfomycin ([Fig. 3A](#f3){ref-type="fig"}) ([@B62], [@B115], [@B128]). Fosfomycin is a broad-spectrum antibiotic that is also used in clinical practice to treat methicillin-resistant *S. aureus* (MRSA) infections ([@B84], [@B127]). Fosfomycin inhibits the first step in cell wall synthesis through covalent modification of the active site cysteine of the MurA enzyme.

To counter the action of this antibiotic, bacteria have evolved fosfomycin detoxification enzymes. *B. subtilis* and *S. aureus* encode FosB, an Mn^2+^-dependent BST. FosB inactivates fosfomycin by catalyzing the nucleophilic addition of BSH to the C2 position of the fosfomycin epoxide ring, resulting in an inactive BS-fosfomycin complex ([@B115]). Strains lacking FosB or BSH are hypersensitive to fosfomycin and the increase in sensitivity is comparable to strains lacking both FosB and BSH, indicating that FosB utilizes BSH as a thiol substrate ([@B40]). In support of this hypothesis, biochemical studies demonstrated that *S. aureus* FosB is significantly more active in the presence of BSH than other LMW thiols ([@B115]).

A second class of BSTs comprised members of the DinB/YfiT superfamily of thiol transferases, which utilize a thiol cofactor to detoxify reactive electrophiles and xenobiotics ([Fig. 3B](#f3){ref-type="fig"}). *B. subtilis* YfiT was identified as a putative BST by structural homology to the mycothiol-*S*-transferase (RV0443) found in *M. tuberculosis* ([@B96]). *In vitro* studies monitoring the reaction of the electrophilic compound monochlorobimane with BSH demonstrated that YfiT ([@B96]) and BstA ([@B106]), a structural homolog found in *S. aureus*, indeed, function as BSTs and are highly specific for BSH as a thiol substrate. The relevant compounds detoxified by BSTs *in vivo* are currently unknown. The only DinB/YfiT family protein with an identified function *in vivo* is the MSH-dependent maleylpyruvate isomerase (*ngcl2918*) from *Corynebacterium glutamicum*, which is essential for growth on aromatic compounds as a carbon source ([@B32]).

BSTs may also be involved in the detoxification of endogenously produced toxins that are byproducts or intermediates during secondary metabolite biosynthesis. In fact, toxic metabolites that are produced during actinorhodin biosynthesis by *Streptomyces coelicolor* appear to be detoxified by formation of an MSH-*S*-conjugate ([@B126]). The formation of this conjugate may be dependent on a DinB/YfiT-like protein.

Toxic electrophiles {#s007}
-------------------

The discovery of BSH as the major LMW thiol in *B. subtilis* led us to postulate that BSH may serve a protective function against the toxic dicarbonyl compound MG in a manner that is functionally analogous to GSH ([Fig. 3C](#f3){ref-type="fig"}). The first hint came from the observation that the gene encoding MGS, *mgsA*, is co-transcribed with the genes encoding the first two enzymes in the BSH biosynthetic pathway, *bshA* and *bshB1*. In fact, strains lacking BSH are more sensitive to added MG ([@B40]).

MG, an α,β unsaturated aldehyde, is a toxic, endogenous byproduct of glycolysis, synthesized by MGS under conditions of excess carbon or phosphate limitation due to an imbalance between the rate of carbon acquisition and the lower segment of glycolysis ([@B129]). The main role of MGS is to restore inorganic phosphate levels. As an electrophile, MG can modify guanine bases in DNA, leading to DNA damage and an increased rate of mutation in surviving cells ([@B33]). Furthermore, MG can react with arginine, lysine, and cysteine residues in proteins, resulting in protein inactivation ([@B72]).

The major mechanism of protection from MG in *Escherichia coli* is the GSH-dependent acidification of the cytoplasm mediated by the KefGB and KefFC K^+^ efflux systems ([@B34]). Exposure to MG leads to the spontaneous formation of the GSH adduct hemithioacetal (HTA). Glyoxalase I (GlxI) catalyzes the formation of *S*-lactoylglutathione (SLG) from HTA ([@B77]). Subsequently, glyoxalase II converts SLG to D-lactate and regenerates GSH ([@B102]). KefGB and KefFC K^+^ efflux systems are directly inhibited by GSH and activated by GSH adducts. Thus, the SLG intermediate is critical for protection from MG stress as it is required for the full activation of the KefGB and KefFC K^+^ efflux pumps ([@B77], [@B87]). The H^+^ influx that accompanies the KefGB and KefFC-mediated K^+^ efflux leads to the cytoplasmic acidification that is sufficient to confer resistance to MG ([@B34]). Interestingly, protection from MG by cytoplasmic acidification does not increase the rate of MG detoxification ([@B33], [@B34]). Rather, cytoplasmic acidification likely protects cells from MG and other electrophiles by protonating nucleophilic residues on DNA, thereby preventing alkylation of DNA by electrophiles ([@B33]).

*B. subtilis* encodes a BSH-dependent MG-detoxification pathway ([Figs. 3C](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}) ([@B11]). Null mutants of the glyoxalase I and II homologs, GlxA (formerly YwbC) and GlxB (formerly YurT), respectively, are more sensitive to MG and function in the same genetic pathway as BSH and a putative BSH-gated K^+^/H^+^ antiporter, KhtSTU (formerly YhaSTU). Upon MG stress, intracellular pH decreases ∼0.4 U, as measured by an intracellular GFP-based pH reporter ([Fig. 4](#f4){ref-type="fig"}). This cytoplasmic acidification is sufficient for protection against MG, since cells treated with the weak membrane-permeant acid sodium acetate before MG exposure are less sensitive to MG.

![**BSH-dependent detoxification of methylglyoxal, leading to cytoplasmic acidification.** Methylglyoxal can be produced as a byproduct of the glycolysis from DHAP. Methylglyoxal reacts spontaneously with BSH, forming BS-hemithioacetal, which is converted to S-lactoyl-BSH by the glyoxalase-I (GlxA) and to lacatate by the glyoxalase-II (GlxB). S-lactoyl-BSH activates the potassium proton antiporter KhtSTU for K-efflux and proton import, leading to cytoplasmic acidification that likely inhibits interaction of methylglyoxal with the DNA to prevent DNA damage. BSH inhibits the antiporter KhtSTU. DHAP, dihydroxyacetone phosphate.](fig-4){#f4}

A GSH-independent MG detoxification pathway is also present in *E. coli*, in which MG is converted directly to D-lactate by the glyoxalase III enzyme, HchA. Using the Phyre2 structural homology search tool, a glyoxalase III homolog, GlxC (formerly YdeA) in *B. subtilis* was identified ([@B11]). GlxC null mutants are more sensitive to MG than wild-type cells, although to a lesser extent than a BSH null mutant. The MG sensitivity of the *glcX bshC* double mutant was additive when compared with the *glxC* and *bshC* single mutants, which suggests that GlxC is a BSH-independent glyoxalase III enzyme and that the major detoxification pathway is BSH dependent ([@B11]).

Methanotrophic and methylotrophic bacteria generate formaldehyde (FA) as an intermediate during the oxidation of methane to carbon dioxide. FA is a toxic carbonyl compound that, similar to MG, is a reactive electrophile and can react with nucleophilic groups in proteins and DNA, leading to protein-protein and protein-DNA crosslinking. In these bacteria, FA is either assimilated by the serine or ribose monophosphate pathway (RuMP) to be used as a major source of cellular carbon or oxidized to generate NADH and formate by LMW thiol-dependent formaldehyde dehydrogenases (Fdh).

Recently, a metabolomics approach identified a role for BSH in FA detoxification in *Bacillus methanolicus* ([@B90]) ([Fig. 3D](#f3){ref-type="fig"}). *B. methanolicus* is a thermotolerant, facultative methylotroph, making it a useful strain for the large-scale production of amino acids from methanol. When grown in the presence of methanol, an *S*-formyl-BSH intermediate was detected in cell lysates by LC-MS. The hydrolysis of related *S*-formyl-GSH is usually catalyzed by *S*-formyl-GSH-hydrolases that are homologs of human esterases and participate in FA oxidation in GSH-producing bacteria ([@B46]). The putative esterase that is specific for hydrolysis of *S*-formyl-BSH is unknown in *B. subtilis*. The BSH-dependent FA oxidation pathway appears to be the most important under conditions where the RuMP and THF pathways are overwhelmed, such as on a rapid shift in carbon source from mannitol to methanol. Non-methanotrophs, such as *B. subtilis*, also use the RuMP pathway to detoxify FA. In addition, transcriptomic and proteomic characterization of the *B. subtilis* response to FA stress led to the identification of AdhA as a putative LMW thiol-dependent Fdh that is induced under FA and MG stress, although its precise role has not been confirmed ([Fig. 3D](#f3){ref-type="fig"}) ([@B98]).

BSH and Metal Homeostasis {#s008}
=========================

Metal ions are essential for life, yet many fundamental questions regarding the size of the cellular metal quota, how it varies with growth conditions, and how it is modulated in response to stress still remain. Metal deficiency leads to a genome-wide response that serves to increase metal import, decrease metal demand, mobilize stored metals, redistribute metals from lower-priority enzymes to support higher-priority needs, and replace metal-dependent enzymes with pathways that are dependent on other cofactors ([@B82]). Conversely, metal excess induces the expression of metal efflux systems to prevent the mismetallation of essential enzymes and the production of ROS ([@B100]). Both metal deficiency and excess are utilized by the host immune system in response to pathogens ([@B23], [@B103]).

The chemical speciation of metals within cells is largely unexplored. Metallation of metalloenzymes, and detection of cellular metal status by metalloregulatory proteins, is governed by the labile metal pool, which is defined as those metal ions that are hydrated or otherwise in a rapidly exchanging form. LWM thiols in eukaryotic and GSH-producing bacteria are known to participate in buffering the labile pool and in detoxifying metal ions. GSH was shown to function together with glutaredoxins in iron-sulfur (FeS)-cluster trafficking since an FeS cluster could be assembled and bridged between the active site Cys of monothiol Grx3/4 and GSH, as demonstrated both *in vitro* and *in vivo* in yeast cells ([@B67], [@B89], [@B108]).

In plants and fungi, GSH is necessary for heavy-metal sequestration as it is the major substrate for the synthesis of the heavy metal-binding peptide phytochelatin ([@B44]). In yeast, resistance to cadmium requires GSH ([@B69]). In contrast, the contribution of LWM thiols to metal ion homeostasis is poorly understood in non-GSH-producing bacteria ([@B45], [@B48], [@B49]). In the next section, we discuss the emerging role of BSH as a key player in metal homeostasis.

Zinc buffering {#s009}
--------------

Between 5% and 10% of proteins require Zn^2+^ as either a structural or catalytic cofactor ([@B3]). Unlike Fe^2+^, which generates cell-damaging hydroxyl radicals in the presence of hydrogen peroxide (H~2~O~2~), Zn^2+^ is not redox reactive, allowing it to be adopted as a structural cofactor in a number of proteins. Zn^2+^ must be kept at a high enough concentration to ensure that the Zn^2+^ quota is sufficient for Zn^2+^ to perform its essential roles. However, since Zn^2+^, in general, binds with higher avidity than most other metals (except for Cu^2+^), Zn^2+^ must not be present in excess so that proteins utilizing other metals are not mismetallated ([@B58]). Thus, the free steady-state Zn^2+^ levels are highly regulated at multiple levels such that they are buffered in with a total intracellular concentration of ∼1 m*M* and a free Zn^2+^ concentration in the ∼p*M* range ([@B101]).

The narrow range of intracellular free Zn^2+^ is set by Zn^2+^ sensing transcription factors ([@B101]). In *B. subtilis*, Zur acts as a sensor of Zn^2+^ limitation and CzrA is a sensor of Zn^2+^ excess ([@B39], [@B88]). These metalloregulators sense the labile Zn(II) pool, consisting of Zn(II) bound reversibly to small molecules, nucleotides, and proteins in a rapidly exchanging form. Under conditions of Zn^2+^ sufficiency, the Zn^2+^-sensing transcription factor Zur represses transcription of the Zn^2+^ uptake systems. When Zn^2+^ is in excess, CzrA is inactivated, leading to derepression of transcription of the *cadA* and *czcD* efflux pumps and Zn^2+^ efflux. Organisms have also evolved Zn^2+^-independent paralogs that can functionally replace Zn^2+^ requiring proteins under Zn^2+^ starvation conditions ([@B1], [@B91]). In addition, Zn^2+^ may be mobilized from a labile Zn^2+^ pool in response to stress under non-steady state conditions. Work from the Maret lab demonstrated that metallothionein (MT), a cysteine-rich, Zn^2+^-binding LMW protein, serves as a zinc "sink" in eukaryotes and is able to control the availability of kinetically available Zn^2+^ in response to oxidative stress ([@B80]).

Since *B. subtilis* utilizes BSH as the major LMW thiol and does not produce MT or GSH, BSH could serve a similar function in metal buffering. BSH has several potential metal coordinating ligands, including a sulfur-containing thiolate, a primary amine, and two carboxylates ([@B97]). Genetic, physiological and biochemical evidence suggests that, in *B. subtilis* and related low G + C *Firmicutes*, BSH serves as the major buffer of the labile Zn^2+^ pool ([Fig. 5](#f5){ref-type="fig"}) ([@B75]). BSH binds Zn^2+^ as a (BSH)~2~:Zn^2+^ complex with an affinity (*K*~a~) of 1.9 × 10^12^ *M*^−2^ ([@B75]). Given that the intracellular concentration of BSH can range from 1 to 5 m*M* ([@B120]), depending on the growth phase, it is reasonable to suggest that BSH can account for ∼1/3 of the total Zn^2+^ pool under Zn^2+^ excess conditions ([@B75]).

![**The functions of BSH in metal homeostasis.** A role for BSH in metal homeostasis has been identified for iron, zinc, and copper. BSH is required for the full activity of FeS requiring proteins in *S. aureus*, possibly as a key component in the assembly and delivery of FeS clusters. BSH is believed to function in an independent, yet overlapping role with the FeS carrier proteins, SufA and Nfu. BSH can also bind zinc with a high affinity and serves as a major cytosolic zinc buffer as demonstrated in *B. subtilis*, allowing the cell to avoid zinc intoxication under conditions of excess. Biochemical evidence also suggests a role for BSH in facilitating the delivery and removal of zinc from the zinc-sensing metalloregulators, Zur and CzrA. Lastly, BSH may also work in concert with CopZ in interacellular copper buffering and delivery to metalloproteins and may protect CopZ from overoxidation through *S*-bacilliothiolation. FeS, iron-sulfur.](fig-5){#f5}

BSH may also have direct effects on Zn^2+^ sensing by Zur and CzrA. *In vitro* experiments monitoring the binding of CzrA to its operator site as a proxy for CzrA metallation status demonstrated that Zn^2+^ dissociation from holo-CzrA was much faster in the presence of BSH. This suggests that BSH can facilitate Zn^2+^ loading and removal into CzrA, presumably through a ligand-exchange mechanism that was analogous to that described for Cu^+^ chaperones ([@B116]). This may provide a mechanism for rapid re-repression of Zn^2+^ efflux if cells experience a sudden shift from Zn^2+^ excess to starvation. Thus, BSH influences Zn^2+^ homeostasis at multiple levels as a significant intracellular Zn^2+^ buffer under conditions of Zn^2+^ excess to prevent intoxication, and as a facilitator of transcription regulation in response to fluctuations in Zn^2+^ levels.

Iron-sulfur cluster assembly {#s010}
----------------------------

The major cytosolic requirements for Fe^2+^ are for utilization in heme-containing enzymes and the assembly of FeS clusters. FeS cluster-containing proteins are involved in a wide range of cellular functions ([@B83]). Many key enzymes in amino acid biosynthesis, carbon metabolism, cofactor biosynthesis, and antibiotic resistance are dependent on FeS cluster-containing enzymes. Thus, inactivation of these enzymes under conditions of Fe^2+^ starvation or oxidative stress is detrimental for proliferation ([@B57]).

A broad phenotypic survey of a *S. aureus* strain lacking BSH revealed many phenotypes that are consistent with defects in FeS biogenesis ([Fig. 5](#f5){ref-type="fig"}) ([@B30], [@B118]). *S. aureus* strains lacking BSH are severely impaired for growth in media lacking leucine (Leu) or isoleucine (Ile). This growth defect could be suppressed by supplementation with either amino acid or Fe^2+^. The activity of key FeS requiring dehydratase enzymes in Leu or Ile biosynthesis is decreased in a BSH null mutant strain. In addition, aconitase activity, an unrelated FeS-dependent enzyme that catalyzes the conversion of citrate to isocitrate, also decreased, suggestive of an overall defect in cellular FeS cluster biogenesis.

The FeS biosynthetic machinery in *S. aureus* is encoded by the *suf* operon, which utilizes cysteine as a sulfur source and an unidentified Fe^2+^ source. On assembly, the FeS clusters are transferred to FeS carrier proteins (Nfu and/or SufA) for delivery to FeS-containing proteins ([@B81]). Genetic analysis suggests that the role of BSH in FeS biogenesis is independent of Nfu and SufA ([@B118]). Thus BSH, Nfu and SufA perform independent, yet overlapping roles in FeS biogenesis.

In yeast, monothiol glutaredoxins together with GSH play a key role in FeS cluster biogenesis and trafficking ([@B17], [@B67], [@B68], [@B89], [@B108]). Grx3/4 were shown to bind a bridging \[2Fe-2S\] cluster *in vitro* that is coordinated by the active-site Cys residue of the Grx domain and GSH as ligands ([@B67], [@B108]). The deficiency of Grx affected the synthesis of Fe/S clusters, heme, and di-iron centers and thus, this Grx FeS center has a crucial role in iron trafficking and sensing in yeast cells. It remains an interesting question for future studies to unravel whether BSH chelates Fe^2+^ directly or is involved in FeS cluster assembly *via* a BSH-containing Brx FeS center that perhaps could function in iron trafficking and sensing.

BSH may also have a role in maintaining the labile Fe^2+^ pool. In bacteria, Fe^2+^ sufficiency is sensed by the Fe^2+^-specific metalloregulator, Fur ([@B63]). On Fe^2+^ sufficiency, *B. subtilis* Fur binds Fe^2+^ at two different sensing sites, leading to DNA binding and repression of its regulon ([@B76]). Fur controls a large and complex regulon, including many iron uptake systems and an iron efflux pump (PfeT) ([@B4]). In addition, Fur indirectly regulates many more genes by repression of a small noncoding RNA (FsrA) and putative RNA chaperones (FbpABC) that are analogous in function to Hfq from enterobacteria, which together mediate an Fe^2+^-sparing response ([@B36], [@B123], [@B124]). A *S. aureus* BSH null strain contains lower levels of Fur-accessible Fe^2+^, as judged by slower transcriptional repression on Fe^2+^ sufficiency of the Fur-regulated *isdB* promoter, which is involved in Fe^2+^ acquisition from heme ([@B118]).

Copper trafficking {#s011}
------------------

Copper plays a critical role in many cellular processes, yet Cu^+^ is highly toxic in excess due to enzyme mismetallation ([@B78], [@B79]). Thus, bacteria have evolved mechanisms to limit intracellular Cu^+^ toxicity by keeping it tightly bound to proteins, thereby limiting deleterious side reactions. Delivery of Cu^+^ into Cu^+^-containing proteins is often mediated by Cu^+^ chaperones, such as Atx1 in yeast ([@B70]) or possibly CopZ in *B. subtilis* ([@B5]). CopZ is a Atx1-like protein that may sequester excess intracellular Cu^+^ and deliver Cu^+^ to the CopA CPx-type ATP-ase for efflux. Recent *in vitro* studies identified *S*-bacillithiolated forms of apo-CopZ as well as CopZ loaded with BSH:Cu^+^ adducts ([Fig. 5](#f5){ref-type="fig"}) ([@B60]). Further biochemical analysis revealed that BSH binds Cu^+^ with a relatively high affinity of β~2~(BSH) = 4 × 10^17^ *M*^−2^ and a stoichiometry of 2 BSH to 1 Cu^+^, indicating a possible role for BSH in intracellular Cu^+^ buffering. Cells lacking BSH are no more sensitive to Cu^+^ than wild-type cells. Interestingly, expression of the CsoR-regulated, Cu^+^-responsive *copZA* operon is induced in the absence of BSH, suggesting elevated levels of labile Cu^+^ and a role for BSH in Cu^+^ buffering ([@B75]). However, the precise *in vivo* role of BSH in Cu^+^ homeostasis remains to be determined.

Functions of BSH in *S. aureus* Virulence {#s012}
=========================================

BSH also plays an important role under infection-like conditions in the *S. aureus* clinical isolates, as shown in two phenotype studies using macrophage infection assays ([@B111], [@B112]). BSH-deficient mutants in clinical MRSA strains COL and USA300 showed a decreased survival in human whole-blood survival assays ([@B111]). In microarray analyses, the biosynthetic operon for staphyloxanthin was upregulated and the staphyloxanthin level was strongly decreased in the *bshA* mutant, suggesting lower radical scavenging ability in the absence of BSH. Staphyloxanthin is a carotenoid pigment that is produced by some *S. aureus* strains and is responsible for the yellow color from which the species name is derived. Staphyloxanthin provides protection against oxidative stress in neutrophil-infection assays and enhances the fitness of *S. aureus* ([@B16]).

Among the various *S. aureus* clonal complexes, it was found that natural BSH-deficient *S. aureus* strains have evolved that belong to the *S. aureus* NCTC8325 lineage (*e.g*., strain SH1000). They carry a *bshC* null mutation due to an 8 bp duplication in the *bshC* gene as a possible remnant of a transposon insertion ([@B95], [@B111], [@B112]). The natural *S. aureus* SH1000 *bshC* mutant was compromised in survival during infection assays using murine macrophages and human epithelial cell lines in comparison to the repaired and *bshC-*complemented *S. aureus* SH1000 strain ([@B111], [@B112]). Thus, BSH is an important virulence factor contributing to pathogen fitness and provides protection against the host-immune system in *S. aureus* clinical MRSA isolates under infection-related conditions.

This makes the BSH biosynthesis enzymes attractive drug targets for the treatment of emerging MRSA infections. In particular, BshB inhibitors would be good candidates for anti-infectives that block biosynthesis and salvage of BSH. Future studies should be directed toward unraveling the mechanisms of virulence control by BSH in *S. aureus*, which could involve *S*-bacillithiolation of key enzymes or regulators.

Protein *S*-Bacillithiolation and Its Reversal by Brx {#s013}
=====================================================

Targets of protein *S*-bacillithiolation in *B. subtilis* and *S. aureus* {#s014}
-------------------------------------------------------------------------

In eukaryotes, protein *S*-glutathionylation functions as an important thiol-protection and redox-regulatory mechanism and is implicated in many physiological and pathophysiological processes, such as neurodegenerative and cardiovascular diseases, cancer, and diabetes ([@B18], [@B42], [@B43]). In *Firmicutes*, BSH plays a related role in a redox modification termed protein *S*-bacillithiolation ([Fig. 6](#f6){ref-type="fig"}) ([@B74]). Protein *S*-bacillithiolation was first discovered as redox modification of the organic hydroperoxide repressor OhrR under cumene hydroperoxide (CHP) stress ([Fig. 7](#f7){ref-type="fig"}). OhrR is inactivated due to *S*-bacillithiolation at its lone Cys15 residue under CHP stress, leading to upregulation of the OhrA peroxiredoxin that is involved in CHP detoxification ([@B35], [@B64]). However, OhrR is also involved in redox sensing of hypochloric acid and is inactivated by *S*-bacillithiolation under NaOCl stress, leading to *ohrA* derepression that confers resistance against NaOCl stress in *B. subtilis* ([@B14]). Thus, *S*-bacillithiolation functions as a redox-switch mechanism to control the activity of the redox-sensing transcription factor OhrR in *B. subtilis* in response to both CHP and NaOCl treatment.

![**Mechanisms of** ***S*-bacillithiolation and its reversal.** Proteins are *S*-bacillithiolated under CHP, HOCl, and diamide stress in *Bacillus* and *Staphylococcus* species. Diamide is a reactive electrophile species leading directly to the formation of mixed BSH disulfides. CHP and HOCl activate thiols to a sulfenic acid (-SOH) and sulfenylchloride (-SCl) intermediates, respectively, that react further with BSH to form *S*-bacillithiolated proteins. In the absence of proximal thiols, -SOH and -SCl are overoxidized to sulfinic or sulfonic acids. Thus, *S*-bacillithiolation serves to protect vulnerable thiols against irreversible overoxidation. The *asterisk* indicates that often active site Cys residues are targets for *S*-bacillithiolation. The reversal of *S*-bacillithiolation is catalyzed by the BrxA/B. Brx, bacilliredoxin; CHP, cumene hydroperoxide.](fig-6){#f6}

![**Physiological roles of** ***S*-bacillithiolations for OhrR and MetE in** ***B. subtilis*** **and for Gap of** ***S. aureus.*** NaOCl leads to *S-*bacillithiolation of OhrR and MetE as main targets in *B. subtilis* that have regulatory roles under NaOCl stress. *S*-bacillithiolation inactivates the OhrR repressor, leading to induction of the OhrA peroxiredoxin that confers resistance to NaOCl and OHP. *S-*bacillithiolation of the methionine synthase MetE at its active site Cys730 and of other enzymes of the Cys and Met biosynthesis pathway (YxjG, PpaC, SerA, MetI) leads to methionine auxotrophy. In *S. aureus*, the glycolytic Gap is the main target for *S*-bacillithiolation under NaOCl stress. *S*-bacillithiolation of the Gap active site Cys151 leads to reversible Gap inactivation and prevents its overoxidation to Cys sulfonic acid. Gap inactivation under oxidative stress might redirect the glycolytic flux into the PPP for NADPH regeneration, as shown in yeast cells. Gap, glyceraldehyde-3-phosphate dehydrogenase; OHP, organic hydroperoxide; PPP, pentose phosphate pathway.](fig-7){#f7}

Although the role of the OhrA peroxiredoxin in the detoxification of organic hydroperoxides to their corresponding alcohols is well known in several bacteria ([@B24]), the function of OhrA in NaOCl detoxification has still to be demonstrated *in vitro*. Moreover, there are two OhrR homologs encoded in the genomes of *S. aureus*, SarZ and MgrA, controlling *ohrA* homologs and large regulons for antibiotics resistance determinants and virulence factors ([@B12]). Evidence for the redox control and structural changes of SarZ and MgrA at the conserved single Cys by *S*-thiolation was demonstrated by using a synthetic thiol, benzene thiol *in vitro* ([@B110]). Recently, the quantitative redox proteomics approach OxICAT revealed increased oxidation of both SarZ and MgrA under NaOCl stress in *S. aureus* USA300, suggesting their redox regulation by *S*-bacillithiolation *in vivo* ([@B56]).

Apart from OhrR, the methionine synthase MetE was identified as the most abundant *S-*bacillithiolated protein in *Bacillus* species under NaOCl stress ([Fig. 7](#f7){ref-type="fig"}). *S-*bacillithiolation of MetE was observed when cells were grown in minimal medium under NaOCl stress and MetE-SSB could be visualized as a major band in BSH-specific Western blots under NaOCl and diamide stress. MetE was *S*-bacillithiolated at its Zn-binding active site Cys730 and at the non-essential surface-exposed Cys719, causing a methionine auxotrophy phenotype under NaOCl stress ([@B12]). MetE is also a main target for *S*-glutathionylation and the most susceptible protein for thiol-oxidation in *E. coli* under diamide treatment ([@B52], [@B66]). *S*-glutathionylation of MetE occurs at a non-conserved Cys645 that is located at the entrance to the active site, also leading to methionine auxotrophy in *E. coli* ([@B52]).

We have shown that the conserved Zn-binding active site forms the mixed disulfide with BSH in *B. subtilis*, which is also target for *S*-mycothiolation in *C. glutamicum* under NaOCl stress ([@B13]). Inactivation of MetE under NaOCl stress in *B. subtilis* is accompanied by an increased transcription of the S-box regulon controlling genes for methionine biosynthesis. It is hypothesized that MetE inactivation could lead to a translation arrest to enable detoxification of hypochlorite and to avoid further protein damage. Further support for this postulated translation stop is provided by the observation that other amino acid biosynthesis enzymes (AroA), protein translation factors (Tuf), and ribosomal proteins (RpsM) are also targets for *S*-thiolation across Gram-positive bacteria ([@B14]).

In *S. aureus*, *S*-bacillithiolation was recently shown to control the activity of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (Gap) of *S. aureus* under NaOCl stress ([Fig. 7](#f7){ref-type="fig"}) ([@B56]). Gap is *S*-bacillithiolated at the conserved active site Cys151, which is a well-known target for various post-translational thiol-modifications, also including *S*-glutathionylation in eukaryotes. The reactivity of the Gap active site was shown to depend on a specific H~2~O~2~-binding pocket, transition state stabilization, and a proton relay mechanism promoting leaving-group departure ([@B51], [@B105]).

In *S. aureus*, Gap contributes as the most abundant Cys protein in the proteome, with 4% to the total Cys proteome of *S. aureus* and the *S*-bacillithiolated Gap was observed as a major band in NaOCl-treated cells using BSH-specific Western blots ([@B56]). Using OxICAT, Gap showed the highest oxidation increase of 29% at the *S*-bacillithiolated active site Cys151 under NaOCl stress. Detailed Gap activity assays in the presence of H~2~O~2~ and NaOCl with or without BSH revealed that Gap inactivation is faster due to *S*-bacillithiolation compared with overoxidation. These results lead to the conclusion that *S*-bacillithiolation of the Gap active site can efficiently prevent its irreversible overoxidation under both H~2~O~2~ and NaOCl treatments. Molecular docking of BSH into the Gap active site was used to model the structure of the *S*-bacillithiolated active site. The model of the Gap-SSB structure suggests that BSH can undergo disulfide formation with Cys151 without major conformational changes. This may explain why the most abundant Cys-protein Gap is the preferred and dominant target for *S*-bacillithiolation inside *S. aureus* cells ([@B56]).

Protein *S*-bacillithiolation is a widespread thiol-protection and redox-regulatory mechanism in different *Firmicutes* under hypochlorite stress, including industrially important *Bacillus* and *Staphylococcus* species, such as *B. subtilis*, *Bacillus amyloliquefaciens*, *Bacillus megaterium*, *Bacillus pumilus*, and the meat-starter culture *Staphylococcus carnosus* ([@B8], [@B14], [@B74]). Eight common and 29 unique *S*-bacillithiolated proteins were identified in the different *Firmicutes* using shotgun proteomics based on the mass increase of 396 Da at Cys residues ([@B14], [@B15]). The complete set of *S*-bacillithiolated proteins (the S-bacillithiolome) includes antioxidant function proteins, such as peroxiredoxins (YkuU), thiol-disulfide oxidoreductases (YumC) and Brx (YphP YqiW, YtxJ), translation factors (Tuf), chaperones (DnaK, GrpE), and several metabolic enzymes involved in the biosynthesis of amino acids, cofactors, and nucleotides. The translation elongation factor TufA, the methionine synthase MetE and its homolog YxjG, the inosine monophosphate dehydrogenase GuaB, and the inorganic pyrophosphatase PpaC belong to the conserved targets for *S*-bacillithiolation across *Firmicutes* bacteria that are also modified by *S*-mycothiolation in Actinomycetes ([@B13]).

Surprisingly, the glycolytic Gap is the major target for *S*-bacillithiolation in *S. aureus* ([@B56]), but Gap is not *S*-bacillithiolated in *Bacillus* species. Instead, the Gap enzyme of *B. subtilis* is oxidized to an intramolecular disulfide in its highly conserved CTTNC motif under NaOCl stress, as confirmed by mass spectrometry ([@B14]). This intracellular disulfide was also shown for the *E. coli* Gap homolog under NaOCl stress, since both Cys residues showed increased oxidations in the OxICAT analysis ([@B65]). However, in *S. aureus* Gap, the second Cys in this CTTNC motif is replaced by a serine explaining the preference of Cys151 for *S*-bacillithiolation under NaOCl stress.

All global *S*-bacillithiolome studies to date identified *S*-bacillithiolated proteins in *Firmicutes* bacteria by mass spectrometry and non-reducing BSH-Western blot analyses under NaOCl and diamide stress, but not under H~2~O~2~ stress *in vivo* ([@B15]). Previously, strongly increased *S*-thiolations were also observed at the global level under diamide stress in *B. subtilis* and *S. aureus* ([@B113]). *S*-glutathionylation requires activation of thiols to sulfenic acid, sulfenylamides, thiyl radicals, thiosulfinate, or *S*-nitrosyl intermediates that, subsequently, react further with GSH to the mixed disulfide ([@B2], [@B41], [@B85], [@B86]). Hypochlorite activates the thiol group *via* chlorination, leading to an unstable sulfenylchloride intermediate that quickly reacts further to generate *S*-bacillithiolations ([Fig. 6](#f6){ref-type="fig"}) ([@B19], [@B47]). Diamide is a reactive electrophile known to form mixed disulfides, including *S*-thiolations in several organisms ([@B113]). The second-order rate constant of the reaction of HOCl with thiols is seven orders of magnitude higher compared with H~2~O~2~ ([@B19], [@B104]), explaining why *S*-bacillithiolation was not observed under H~2~O~2~ stress *in vivo*. Moreover, the pathogen *S. aureus* exhibits a remarkable resistance to 200 m*M* H~2~O~2~ due to efficient detoxification mechanisms that allow the survival under infection conditions ([@B55], [@B73]).

Apart from H~2~O~2~, *S. aureus* encounters HOCl during infections by activated neutrophils that is produced by myeloperoxidase ([@B134]), and hence, *S*-bacillithiolation serves as a major thiol-protection mechanism of essential enzymes, such as Gap under infection-related HOCl stress conditions. It will be interesting to uncover the targets for *S*-bacillithiolation during infections, or in the anterior nares as the natural niche of *S. aureus* in future studies.

The BrxA and BrxB function in protein de-bacillithiolation {#s015}
----------------------------------------------------------

The Trx-fold proteins YtxJ, BrxA (YphP), and BrxB (YqiW) were identified as *S*-bacillithiolated in *B. subtilis* and *S. carnosus* that co-occur with the BSH biosynthesis enzymes (BshA, BshB, BshC) only in BSH-producing *Firmicutes* bacteria and were suggested to function as Brx in the reversal of *S*-bacillithiolations ([Fig. 8A, B](#f8){ref-type="fig"}) ([@B15]). YtxJ is suggested as a monothiol Brx with the active site Cys located in a conserved TCPIS motif.

![**Structure of the BrxA (YphP) of** ***B. subtilis*** **(A), Brx redox pathway (B), principle of Brx-roGFP2 biosensor oxidation (C), and ratiometric change of excitation spectra of Brx-roGFP2 by BSSB** ***in vitro*** **(D).** **(A)** The structure of the BrxA (YphP) with the CGC active site motif was generated by using the software Phyre2 and PyMol. **(B)** BrxA reduces *S-*bacillithiolated proteins, resulting in Brx-SSB formation. Recycling of BrxA may require BSH and an NADPH-dependent BSSB reductase that could be YpdA. **(C)** The Brx-roGFP2 biosensor reacts first with BSSB at the active site Cys of Brx, leading to Brx-SSB formation, subsequent transfer of the BSH moiety to the coupled roGFP2, and re-arrangement to the roGFP2 disulfide. The roGFP2 disulfide causes a change of the 405/488 nm excitation ratio. **(D)** Brx-roGFP2 reacts very fast with purified 100 μ*M* BSSB, as shown by the ratiometric change in the excitation maxima at 405 and 488 nm. For fully oxidized and reduced probes, Brx-roGFP2 was treated with 5 m*M* diamide and 10 m*M* DTT, respectively. The Brx-roGFP2 fluorescence excitation spectra were monitored by using the Clariostar microplate reader. Adapted from a previous publication ([@B73]). BSSB, oxidized bacillithiol disulfide.](fig-8){#f8}

BrxA (YphP) and BrxB (YqiW) are DUF1094-family proteins with unusual CGC active site motifs, rather than the more common CxxC spacing seen in glutaredoxin ([@B38], [@B40]). BrxA was originally suggested to function as a thiol-disulfide isomerase based on its high standard redox potential of *E*^0′^ = −130 mV ([@B22]). However, both BrxA and BrxB function in the reduction of the *S*-bacillithiolated MetE and OhrR *in vitro*, thereby demonstrating Brx activity ([@B38]). The BrxBCGA-resolving Cys mutant could regenerate DNA-binding activity of *S*-bacillithiolated OhrR *in vitro*, but *S*-cysteinylated OhrR could not be reactivated. MetE de-bacillithiolation was catalyzed by the BrxBCGA mutant as revealed by non-reducing BSH-specific Western blot analysis and mass spectrometry, but MetE reactivation could not be demonstrated *in vitro*. In *S. aureus*, Gap is the major *S*-bacillithiolated protein under NaOCl stress and Gap activity could be fully restored by using the BrxA (YphP) homolog SAUSA300_1321 (Brx) and the BrxCGA-resolving Cys mutant *in vitro* ([@B56]).

In conclusion, the BrxA and BrxB have been characterized to catalyze the de-bacillithiolation of two essential metabolic enzymes (MetE and Gap) and of the redox-sensing regulator OhrR in *B. subtilis* or *S. aureus*. These results provide evidence for the function of glutaredoxin-like Brx in industrially and medically important BSH-producing bacteria. However, phenotypic analyses of *brxA* and *brxB* single and double mutants revealed no significant growth phenotypes under NaOCl stress in *B. subtilis* ([@B38]). Thus, the Brx pathway is not essential and the Trx pathway might be alternatively involved in the de-bacillithiolation in *B. subtilis.*

A Brx-roGFP2 biosensor monitors dynamic changes in the BSH redox potential in *S. aureus* {#s016}
-----------------------------------------------------------------------------------------

Recently, Brx (YphP) was fused to redox-sensitive GFP (roGFP2) to construct a genetically encoded Brx-roGFP2 biosensor to monitor dynamic changes in the BSH redox potential in *S. aureus* ([Fig. 8C, D](#f8){ref-type="fig"}) ([@B73]). Brx-roGFP2 responds specifically only to physiological concentrations of BSSB *in vitro*, but it does not react with other thiol disulfides (cystine, GSSG, MSSM, CoASH disulfides). This further confirms the specificity of Brx for the reduction of BSH mixed disulfides in *S. aureus*.

The specificity of the Brx-roGFP2 biosensor to low doses of BSSB was shown to depend on the Brx active site *in vitro*, whereas direct responses of the roGFP2 to the oxidants *in vivo* could not be excluded. Brx-roGFP2 was shown to react very fast in *S. aureus* COL to low doses of 20--100 μ*M* NaOCl *in vivo*, but high doses of a maximum of 100 m*M* H~2~O~2~ did not lead to complete biosensor oxidation. This confirms the high reactivity of NaOCl inside *S. aureus* that requires fast thiol protection by *S*-bacillithiolation to avoid the overoxidation of thiols. The weak biosensor response to H~2~O~2~ can be explained by the high level of peroxide resistance in *S. aureus.*

This Brx-roGFP2 biosensor was further applied to investigate the involvement of oxidative stress in the killing mode of antibiotics in *S. aureus* ([@B73]). The role of ROS in the mechanism of action of bactericidal antibiotics has been a subject of controversy ([@B61], [@B71]). Antibiotics that are commonly used to treat *S. aureus* infections were selected that target the RNA polymerase (rifampicin), cell-wall biosynthesis (fosfomycin, ampicillin, oxacillin, and vancomycin), protein biosynthesis (gentamycin, lincomycin, erythromycin, and linezolid), and DNA replication (ciprofloxacin). These different antibiotics classes did not lead to changes in the BSH redox potential at sub-lethal concentrations, indicating that these antibiotics do not impose strong oxidative stress in *S. aureus*.

These results are consistent with roGFP2 biosensor results obtained in *Salmonella* under antibiotic treatment ([@B131]). However, due to its high peroxide resistance, *S. aureus* might be able to quickly detoxify ROS generated during antibiotic treatment. In the case of fosfomycin, BSH is directly required as a cofactor for FosB for detoxification in *S. aureus* ([@B111]). However, previous studies found no correlation between the level of fosfomycin resistance and BSH levels in different *S. aureus* clinical isolates, and no increased BSH redox potential was measured under fosfomycin treatment in *S. aureus* COL.

The Brx-roGFP2 biosensor was further expressed in two MRSA isolates, *S. aureus* COL and USA300, and the latter is highly virulent community-acquired MRSA. An increased BSH redox potential was measured during the entry into stationary phase in both strains, ranging from −300 to −270 mV in COL and from −300 to −235 mV in USA300 along the growth curve. Our future studies are directed to apply this Brx-roGFP2 biosensor for screening of the BSH redox potential across *S. aureus* isolates of different clonal complexes to reveal the differences in pathogen fitness and in their ROS detoxification capacities as defense mechanisms against the host immune system.

Concluding Remarks {#s017}
==================

In a previous review in this journal ([@B50]), written soon after the discovery of BSH, readers were introduced to this novel thiol and given a preview of how the field might develop, guided by analogy with the prior extensive work on GSH and, to a lesser extent, MSH. Many of the predictions made at that time have held true, but there have also been many surprises as well as frustrations. Here, we briefly highlight some of the pressing questions in the field that have not yet been resolved, although ongoing efforts will surely work to address these challenges.

Although the biosynthetic pathway of BSH is now well established, and extensive structural and biochemical studies have led to a detailed understanding of this process, the actual reaction catalyzed by BshC is still undetermined. The analogous enzyme for MSH synthesis uses aminoacylated tRNA^Cys^ as an activated form of Cys. We assume that BshC also requires an activated form of Cys, but the identity of this last substrate is unknown. Another key "missing" activity for our understanding of BSH biology is the BSSB reductase. Certainly, the *B. subtilis* YpdA protein (a TrxR homolog) is an attractive candidate, but attempts to demonstrate BSSB activity biochemically have been unsuccessful.

Although many of the proteins involved in the core metabolism of BSH are, by now, known, including the biosynthesis pathway and Brx, many BSH-utilizing enzymes and accessory functions are yet to be discovered. There are several peroxidases annotated as Gpx, thiol-peroxidase, or thiol-dependent peroxiredoxin in *Bacillus* and *Staphylococcus* species that could use BSH as a thiol cofactor for peroxide detoxification ([Fig. 3E](#f3){ref-type="fig"}). It is also unclear as to whether BSH (or perhaps BSSB) is imported or exported from cells. In *E. coli*, GSH is exported to the periplasm ([@B109]), but an analogous process for BSH is not established. It is worth noting that *B. subtilis* has multiple importers assigned as having a role in cystine uptake ([@B9]), but it is not known as to whether one or more may, in addition, or instead, use BSSB as a substrate.

Although the role of BSH in thiol redox chemistry is well established, there are also other aspects that are still largely unexplored. As noted earlier, in some cases, BSH may play a key role in protecting cells against H~2~S stress ([@B122]), and by analogy with GSH a role in protection against reactive nitrogen species can be predicted. Although BSH has already been investigated for its role in buffering of Zn^2+^ ([@B25], [@B75]) and in the assembly of FeS clusters ([@B30], [@B117], [@B118]), many details remain to be discovered, such as the possible roles of BSH and other thiols together with Brx (glutaredoxin-like enzymes) in bridging FeS clusters, analogous to the role of GSH and Grx proteins in iron trafficking and sensing in GSH-producing eukaryotic organisms.

Similarly, proteomics studies have documented an abundance of protein *S*-bacillithiolation as a major post-translational modification under oxidative stress conditions ([@B14], [@B15], [@B56], [@B64], [@B74], [@B107]), but the pathways that reverse this modification (Brx) and the consequences for enzyme activity are still only now emerging. On a broader level, a clear picture has not yet emerged as to which bacteria synthesize BSH instead of GSH (or MSH), and whether one offers specific advantages over the other. We look forward to the continued rapid progress in this area and the resolution of these questions, and others not yet even imagined.
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Bca

:   BSH *S*-conjugate amidase

Brx

:   bacilliredoxin

BSH

:   bacillithiol

BshA

:   glycosyltransferase for GlcNAc-Mal biosynthesis

BshB

:   deacetylase-producing GlcN-Mal

BshC

:   cysteine ligase for BSH biosynthesis

BSSB

:   oxidized bacillithiol disulfide

Bst

:   BSH-S-transferases

CA-MRSA

:   community-acquired MRSA

CHP

:   cumene hydroperoxide

CoASH

:   coenzymeA

Cys

:   cysteine

DHAP

:   dihydroxyacetone phosphate

EGT

:   ergothioneine

FA

:   formaldehyde

Fdh

:   formaldehyde dehydrogenases

FeS

:   iron-sulfur

Gap

:   glycolytic glyceraldehyde −3-phosphate dehydrogenase

GlcNAc

:   N-acetyl glucoseamine

GlxA/B

:   glyoxalases A and B

Grx

:   glutaredoxin

GSH

:   glutathione

GSSG

:   oxidized glutathione disulfide

Gst

:   GSH-S-transferases

H~2~O~2~

:   hydrogen peroxide

H~2~S

:   hydrogen sulfide

HTA

:   hemithioacetal

LC-MS/MS

:   liquid chromatography tandem mass spectrometry

LMW

:   low molecular weight

Mal

:   malate

Met

:   methionine

MG

:   methylglyoxal

MgsA

:   methylglyoxal synthase

MRSA

:   methicillin-resistant *Staphylococcus aureus*

Mrx1

:   mycoredoxin1

MSH

:   mycothiol

MT

:   metallothionein

NADH

:   nicotinamide adenine dinucleotide

NADPH

:   nicotinamide adenine dinucleotide phosphate

NaOCl

:   sodium hypochlorite

OHP

:   organic hydroperoxide

OhrR

:   organic hydroperoxide repressor

PPP

:   pentose phosphate pathway

protein-SSB

:   BSH protein mixed disulfide

roGFP2

:   redox-sensitive green fluorescent protein

ROH

:   organic alcohol

ROS

:   reactive oxygen species

RuMP

:   ribose monophosphate pathway

SLG

:   *S*-lactoylglutathione

T(SH)2

:   trypanothione

Trx

:   thioredoxin

TrxR

:   thioredoxin reductase
